---
$id: https://graph.org.ai/products/commodity/51182426
$type: Product
source: UNSPSC
code: "51182426"
title: "Cinacalcet"
class: "51182400"
classTitle: "Calcium regulators and calcium salts"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinacalcet

**UNSPSC Code**: 51182426
**Class**: [Calcium regulators and calcium salts](Calcium regulators and calcium salts.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula C22H22F3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UAZ6V7728S, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)- but generally known as cinacalcet, which bears US NIH Compound Identifier 156419. European Medicines Agency schedules Cinacalcet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20068. The term CINACALCET is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules cinacalcet in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cinacalcet under HS 29214980 and SITC 51454. As of Q4 2014, CINACALCET remains the US FDA Preferred Term for this commodity. Cinacalcet bears US NLM identifiers UMLS ID C1337242 and NCI Concept Code C74100. SMILES: FC(F)(F)C1CC(CCCNC(C2C3C(CCC2)CCCC3)C)CCC1.

